Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)
Abstract
Background: Cannabidiol (CBD) is an approved treatment for childhood epilepsies and a candidate treatment for several other CNS disorders. However, it has poor oral bioavailability. We investigated the effect of a novel lipid…